The global lab automation market is characterized by high precision equipment that assist in various laboratory processes including sample handling, sample tracking, sample storage, liquid handling, and data management. Automated laboratory equipment helps improve workflow efficiencies, reduce manual errors, and minimize laboratory costs through optimized resource utilization.

The Global Lab Automation Market is estimated to be valued at US$ 4,903.9 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the lab automation market include Tecan Trading AG, PerkinElmer Inc., Danaher, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Inc., Hamilton Company, COPAN Diagnostics Inc., Abbott, Merck KGaA, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, UiPath, Porvair Sciences, SPT Labtech Ltd, Endress+Hauser Group Services AG, Automata, accroma, Molecular Devices, LLC, Beckman Coulter, Inc., BD, Reshape Biotech, and Peak Analysis & Automation. The increasing prevalence of chronic diseases and growing demand for accurate test results is propelling the demand for automated equipment in clinical laboratories and research institutes. Technological advancements including artificial intelligence, robotics, and internet of things are enabling greater integration of automated workflows in laboratories.

Market Trends

One of the key trends in the lab automation market is the growing adoption of total lab automation solutions which integrate all the discreet processes and instruments in a laboratory. This helps achieve complete walkaway automation. Another major trend is the increasing usage of robots for sample transport within laboratories to minimize human errors and improve throughput.

Market Opportunities

The rising focus on developing personalized medicine presents an opportunity for lab automation solutions incorporating robotics, artificial intelligence, and data analytics. Integration of automation technologies such as 3D printing with key lab processes also provides new avenues for market growth. Increased collaborations between lab automation players and end users is another opportunity that can help address specific automation needs.

In terms of value, the lab automation market is currently concentrated in North America and Western Europe owing to higher healthcare spending, presence of leading life sciences companies and advanced research infrastructure in countries like the US, Germany, UK and France. The US dominates the North American market due to large pharma and biotech industry and significant funding for healthcare modernization initiatives including lab automation.

Asia Pacific is poised to be the fastest growing regional market during the forecast period driven by increasing healthcare expenditure, low labor costs and expanding biopharma industry in China, India, Japan and South Korea. Countries like China and India are witnessing heavy investments towards building state-of-the-art clinical testing and research facilities which favors automated solutions. Growth opportunities also exist in other emerging economies of Latin America and Middle East & Africa as they aim to strengthen healthcare systems and improve access to diagnostics through lab automation.